Hypertensive retinopathy revisited: Some answers, more questions

British Journal of Ophthalmology

Volumn 89, Issue 12, 2005, Pages 1646-1654

  Grosso, Andrea ^a   Veglio, F ^a   Porta, M ^a   Grignolo, F M ^a   Wong, T Y ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN HEXETIL;

ARTERY OCCLUSION; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIABETES MELLITUS; EYE DISEASE; GLAUCOMA; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; MEDICAL RESEARCH; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; RETINA EXAMINATION; RETINA MACULA AGE RELATED DEGENERATION; RETINOPATHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; TARGET ORGAN;

DIABETIC RETINOPATHY; EYE DISEASES; HUMANS; HYPERTENSION; RETINAL DISEASES; RISK ASSESSMENT;

EID: 28444455629     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.072546     Document Type: Review

References (118)

1. Chobanian AV. Control of hypertension - an important national priority. [Editorial] N Engl J Med, 2001;345:534-5.
2. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
3. Gorelick PB. New horizons for stroke prevention PROGRESS and HOPE. Lancet Neurology 2002;1:149-56.
4. Wolf-Maier K, Cooper RS, Kramer, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17, Epub 2003 Nov 24.
5. Giampaoli S, Palmieri L, Chiodini P, et al. The global cardiovascular risk chart. Ital Heart J Suppl 2004;5:177-85.
6. Tso M, Jampol Lee M. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89:1132-45.
7. Dollery CT, Ramalho PS, Patterson JW. Retinal vascular alterations in hypertension. In: Gross F, ed. Antihypertensive therapy; principles and practice, an international symposium. New York: Springer, 1966:152.
8. Goto I, Kimoto K, Katsuki S, et al. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and non cerebrovascular diseases. Sroke 1975;6:263-9.
9. Wells RE, Herman M, Gorlin R. Microvascular changes in coronary heart disease. Circulation 1966;237:33-4.
10. Wise GN, Dollery CT, Henkind P. The retinal circulation. New York: Harper and Row, 1971:325.
11. Chatterjee S, Chattopadhya S, Hope-Ross M, et al. Hypertension and the eye: changing perspectives. J Human Hypertens 2002;16:667-75.
12. Guidelines Committee. 2003 European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 2003;21:1011-53.
13. Chobonian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52.
14. World Health Organization/International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) Statement on Management of Hypertension. J Hypertens 2003;21:1983-92.
15. Williams B, Poulter NR, Brown MJ, BHS guidelines working party, for the British Hypertension Society, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40.
16. Sharrett AR, Hubbard LD, Cooper, et al. Retinal arteriolar diameters and elevated blood pressure. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999;150:263-70.
17. Hubbard L, Brothers RJ, King WL, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269-80.
18. Wong TY, Klein R, Klein BEK, et al. Retinal microvascular abnormalities and their relations with hypertension, cardiovascular diseases and mortality. Surv Ophthalmol 2001;46:59-80.
19. Klein R, Klein BEK, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1997;95:329-48.
20. Wang JJ, Mitchell P, Leung H, et al. Hypertensive retinal wall signs in a general older population: the Blue Mountains Eye Study. Hypertension 2003;42:534-41.
21. Wong TY, Klein R, Klein BE, et al. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci 2003;44:4644-50.
22. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol 2002;86:1007-13.
23. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000;20:1644-50.
24. Couper DJ, Klein R, Hubbard L, et al. Reliability of retinal photography in the assessment of retinal microvascular characteristics. The Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002;133:78-88.
25. Stolk RP, Vingerling JR, de Jong PT, et al. Retinopathy, glucose, and insulin in an elderly population: the Rotterdam Study. Diabetes 1995;44:11-15.
26. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004;351:2310-17.
27. Leung H, Wang JJ, Rochtchina E, et al. Dyslipidaemia and microvascular disease in the retina. Eye 2004 Sep 3; Epub ahead of print.
28. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and ten-year cardiovascular mortality. A population-based case-control study. Ophthalmology 2003;110:933-40.
29. Wong TY, Klein R, Sharrett AR, et al. Atherosclerosis Risk in Communities Study. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 2004;140:248-55.
30. Wong TY, Shankar A, Klein R, et al. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 2004;329:79.
31. Smith W, Wang JJ, Wong TY, et al. Retinal arteriolar narrowing is associated with 5-year incident sever hypertension: the Blue Mountains Eye Study Hypertension. 2004;44:442-7, Epub 2004 Aug 09.
32. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA 2002;287:1153-9.
33. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of diabetes in middle-aged persons. JAMA 2002;287:2528-53.
34. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke. The Atherosclerosis Risk in Communities Study. Lancet 2001;358:1134-40.
35. Wong TY, Klein R, Sharret R, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74.
36. Wong TY, Klein R, Sharret R, et al. Retinal microvascular abnormalities and cognitive impairment in middle aged persons. The Atherosclerosis Risk in Communities Study. Stroke 2002;33:1487-92.
37. Tekin O, Cukur S, Uraldi C, et al. Relationship between retinopathy and cognitive impairment among hypertensive subjects. A case-control study in the Ankara-Pursaklar region. Eur Neurol 2004;52:156-61.
38. Nakayama T, Date C, Yokoyama T, et al. 15.5 Year follow up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 1997;28:45-52.
39. Garner A, Ashton N, Tripathi T, et al. Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol 1982;89:1132-45.
40. Conlan MG, Folsom AR, Finch A. Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. Thromb Haemost 1993;70:380-5.
41. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
42. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscl Thromb Vasc Biol 1998;18:1359-62.
43. Delles C, Michelson G, Harazny J, et al. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004;35:1289-93, Epub 2004 Apr 08.
44. Koss MC. Functional role of nitric oxide in regulation of ocular blood flow. Eur J Pharmacol 1999;374:161-74.
45. Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res 2001;20:823-47.
46. White RP, Vallance P, Markus HS. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond) 2000;99:555-60.
47. White RP, Deane C, Vallance P, et al. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 1998;29:467-72.
48. Sato E, Sakamoto T, Nagaoka T, et al. Role of nitric oxide in regulation of retinal blood flow during hypercapnia in cats. Invest Ophthalmol Vis Sci 2003;44:4947-53.
49. Buerk DG, Atochin DN, Riva CE. Investigating the role of nitric oxide in regulating blood flow and oxygen delivery from in vivo electrochemical measurements in eye and brain. Adv Exp Med Biol 2003;530:359-70.
50. Luksch A, Polska E, Imhof A, et al. Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci 2003;44:734-9.
51. Schmetterer L, Findl O, Fasching P, et al. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 1997;46:653-8.
52. Wong TY, Duncan BB, Golden SH, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 2004;45:2949-54.
53. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease. An update. Hypertension 2001;37:1053-9.
54. Estacio RO, Jeffers BW, Gifford N, et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(Suppl 2):B54-64.
55. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26:S33-S50.
56. Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-19.
57. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.
58. Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and visual loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 2004;122:1631-40.
59. Knowler WC, Bennet PH, Ballintine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med 1980;302:645-50.
60. Caballero AE. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 2005;36:241-9.
61. Schram MT, Stehouwer CD. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 2005;37(Suppl 1):49-55.
62. Landsberg L, Molitch M. Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens 2004;26:621-8.
63. El-Alat F, McFarlane SI, Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 2004;6:215-23.
64. Dahlof B, Stenkula S, Hansson L. Hypertensive retinal vascular changes. Relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Blood Press 1992;1:35-44.
65. Heidbreder E, Huller U, Schafer B, et al. Severe hypertensive retinopathy. Increased incidence in renoparenchymal hypertension. Am J Nephrol 1987;7:394-400.
66. Biesenbach G, Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994;41:211-18.
67. Wong TY, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction: the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 2004;15:2469-76.
68. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hypertension 1997;30:1135-43.
69. Cuspidi C, Meani S, Salerno M, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004;22:2095-102.
70. Cuspidi C, Macca G, Salerno M, et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J 2001;2:702-6.
71. Viazzi F, Parodi D, Leoncini G, et al. Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. J Hypertens 2004;22:907-13.
72. Dodson PM, Kritzinger EE. Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997. Eye 1997;11(Pt 1):3-11.
73. Sperduto R, Holler R. Systemic hypertension and age-related maculopthay in the Framingham Study. Arch Ophthalmol 1986;104:216-19.
74. Bressler S, Maguire M, Bressler N, et al. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 1990;108:1442-7.
75. The Eye Disease Case Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701-8.
76. Klein R, Klein B, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. Ophthalmology 1993;100:406-14.
77. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularisation in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Arch Ophthalmol 1997;115:741-7.
78. Tielsch JM, Katz J, Sommer, et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995;113:216-21.
79. Jonas JB, Grundler AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol 1998;236:202-6.
80. Ogden LG, HE J, Lydick E, et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to JNC VI risk stratification. Hypertension 2000;35:539-43.
81. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999;34:267-72.
82. Karter Y, Curgunlu A, Altinisik S, et al. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press 2003;12:307-13.
83. Bidlingmeyer I, Burnier M, Bidlingmeyer M. Isolated office hypertension: a prehypertensive state? J Hypertens 1996;14:327-32.
84. Falkner B, Daniels SR. Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension 2004;44:387-8, Epub 2004 Sep 7.
85. Davis PH, Dawson JD, Riley WA, et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001;104:2815-19.
86. Arnett DK, Glasser SP, McVeigh G, et al. Blood pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study. Am J Hypertens 2001;14:200-5.
87. Knoflach M, Kiechl S, Kind M, et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 2003;108:1064-9.
88. Sanchez A, Barth JD, Zhang L. The carotid artery wall thickness in teenagers is related to their diet and the typical risk factors of heart disease among adults. Atherosclerosis 2000;152:265-6.
89. Barnes VA, Treiber FA, Davis H. Impact of transcendental meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res 2001;51:597-605.
90. Daniels SR, Lipman MJ, Burke MJ, et al. The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension. Am J Ophthalmol 1991;111:205-8.
91. Daniels SR, Lipman MJ, Burke MJ, et al. Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Hum Hypertens 1993;7:223-8.
92. Wegmann-Burns M, Gugger M, Goldblum D. Hypertensive retinopathy. Lancet 2004;363:456.
93. Wong TY. Is retinal photography useful in the measurement of stroke risk? Lancet Neurol 2004;3:179-83.
94. Mitchell P, Leung H, Wang JJ. Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study. Ophthalmology 2005;112:245-50.
95. Klein R, Klein BE, Tomany SC. The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam Eye Study. Am J Ophthalmol 2004;137:435-44.
96. Papastathopoulos KI, Jonas JB. Follow up of focal narrowing of retinal arterioles in glaucoma. Br J Ophthalmol 1999;83:285-9.
97. Dumskyj MJ, Aldnington SJ, Dore CJ. The accurate assessment of changes in retinal vessel diameter using multiple frame echocardiography synchronised fundus photography. Curr Eye Res 1996;15:625-32.
98. Knudtson MD, Klein BEK, Klein R, et al. Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 2004;88:57-61.
99. Hague S, Hill DW. Postural changes in perfusion pressure and retinal arteriolar calibre. Br J Ophthalmol 1988;72:253-57.
100. Simon J, Svojgrova M, Simecek K, et al. Quantitative assessment of retinal vessel in relation to blood pressure. Hum Biol 1974;46:605-11.
101. Lanigan LP, Clark CV, Hill DW. Retinal circulation responses to systemic autonomic nerve stimulation. Eye 1988;4:12-17.
102. Larsen M, Berdiin Calmorn L, Bonnelycke M, et al. Retinal artery and vein diameters during pregnancy in diabetic women. Invest Ophthalmol Vis Sci 2005;46:709-13.
103. Bressler NM. Retinal arteriolar narrowing and risk of coronary heart disease. Arch Ophthalmol 2003;121:113-1.
104. Thybo NK, Stephens N, Cooper A, et al. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-81.
105. Levy BI, Ambrosio G, Pries AR, et al. Microcirculation in hypertension: a new target for treatment? Circulation 2001;104:735-40.
106. Rizzoni TD, Porteri E, Boari GEM, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003;108:2230-5.
107. Ruilope LM, Schiffrin EL. Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use? Hypertension 2001;38:537-42.
108. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertension 1984;6(Pt 2):158-62.
109. Sabbatini M, Tomassoni D, Di Tullio MA, et al. Neuroprotective effect of treatment with calcium antagonists on hypertensive retina. Clin Exp Hypertens 2002;24:727-40.
110. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45:2129-34.
111. Prandoni P, Bilora F, Marchiori A, et al. An association between atheroslerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
112. Vink H, Constantinescu AA, Span JA, et al. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 2000;101:1500-2.
113. Klein R, Klein BE, Moss S, et al. Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2003;110:2118-25.
114. Klein R, Klein BE, Moss S, et al. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2004;122:76-83.
115. Keen H, Chlouverakis C. Metabolic factors in diabetic retinopathy. In: Graymore CN, ed. Biochemistry of the retina. London: Academic Press, 1965:123-38.
116. Liao D, Wong TY, Klein R, et al. Relationship between carotid artery stiffness and retinal arteriolar narrowing in healthy middle-aged persons. Stroke 2004;35:837-42.
117. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and their prognosis. Am J Med Sci 1939;197:332-43.
118. Porta M, Grosso A, Veglio F. Hypertensive retinopathy: there's more than meets the eye. (Review) J Hypertens 2005;23:683-96.